Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct

Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct

US Patent 9783821 · Granted Oct 10, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified immunocyte, method for producing modified immunocyte and utilization th2023
Modified immunocyte, method for producing modified immunocyte and utilization th2023
Modified immunocyte, method for producing modified immunocyte and utilization th2023
Spray chamber, sample atomization and introduction device, analysis device, and 2023
Method for treating cancer using artificial adjuvant cell (aAVC)2023
Adjuvant composition and use thereof2022
Cell for immunotherapy, including modified nucleic acid construct encoding Wilms2021
Immunotherapy using allo-NKT cells, cells for immunotherapy in which alpha chain2020
Memory invariant NKT cell marker2019
Memory invariant NKT cell marker2019
Cell for immunotherapy, including modified nucleic acid construct encoding Wilms2019
Nebulizer and analyzer2016